RAC1 and neoplasm: IFN-γ activates the RhoGDI2/Rac1/NF-κB pathway in tumor cells to reduce the production of the pro-tumor cytokine CXCL8, promoting tumor apoptosis (169) and reducing CXCR2+ M2 macrophages (170).